Consistently, the in vivo xenograft models confirmed that knockdown of BCL6 partially abolished the accelerated tumor growth and the increased tumor size/weight induced by overexpression of LINC00152 (P < 0.05, Figure 7D). This evidence concerns the gene BCL6 and neoplasm.